Michael Morrissey
Fortuna: 138 M $ al 31/12/2025
Cargos activos de Michael Morrissey
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EXELIXIS, INC. | Director/Miembro de la Junta | 22/07/2010 | - |
| Director Ejecutivo | 22/07/2010 | - | |
| Presidente | 22/07/2010 | - | |
| Director Técnico/Científico/I+D | 01/01/2007 | 22/07/2010 | |
| VERA THERAPEUTICS, INC. | Presidente | 24/05/2022 | - |
| Independent Dir/Board Member | 24/05/2022 | - |
Historial de carrera de Michael Morrissey
Antiguos cargos conocidos de Michael Morrissey.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
XWPharma Ltd.
XWPharma Ltd. Develops drug products for neurological disorders | Director/Miembro de la Junta | 16/12/2020 | 01/04/2023 |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Engages in development of engineered T-cell therapeutics for the treatment of cancer | Director/Miembro de la Junta | 01/01/2022 | 01/11/2022 |
Berlex Biosciences | Corporate Officer/Principal | 01/01/1991 | 01/01/2000 |
Ciba-Geigy Corp.
Ciba-Geigy Corp. Manufactures physician and surgical equipment | Director Técnico/Científico/I+D | 01/01/1986 | 01/01/1991 |
Formación de Michael Morrissey.
Estadísticas
Internacional
| Estados Unidos | 8 |
| China | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Ciba-Geigy Corp.
Ciba-Geigy Corp. Manufactures physician and surgical equipment | |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Develops drug products for neurological disorders | |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Engages in development of engineered T-cell therapeutics for the treatment of cancer | |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases |
- Bolsa de valores
- Insiders
- Michael Morrissey
- Experiencia
















